TuesdayFeb 20, 2018 10:23 am

QualityStocksNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Preparing for Planned Q1 Takeover of Cannevert Therapeutics

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), alongside research arm Cannevert Therapeutics Ltd., this morning announced that it is in the process of obtaining a fairness opinion from Davidson & Company LLP of Vancouver, Canada, regarding Veritas’ planned acquisition of the remaining 20 percent of Cannevert in the first quarter of 2018. Per the update, a fairness opinion is defined as “any written communication containing a conclusion as to the fairness of a proposed transaction to security holders, from a financial point of view.” Davidson & Company is expected to perform this…

Continue Reading

FridayFeb 16, 2018 1:12 pm

QualityStocksNewsBreaks – Marijuana Company of America, Inc. (MCOA) Intends to Further Diversify its Portfolio in the Booming Cannabis Industry

Marijuana Company of America (OTC: MCOA) has operations at various points in the cannabis and industrial hemp industries, and plans to further diversify its portfolio. An article discussing the company reads: “The company, established in 2015 in California by Don Steinberg and Charles Larsen, is set to execute its vision of creating a diverse portfolio of cannabis- and hemp-based businesses. MCOA has already established a commanding presence at various points in the cannabis and industrial hemp markets, as well as the related services supply chains. … Meanwhile, MCOA’s wholly owned subsidiary, hempSMART™, Inc., continues its mission of bringing high quality…

Continue Reading

FridayFeb 16, 2018 1:06 pm

QualityStocksNewsBreaks – Medical Innovation Holdings, Inc. (MIHI) Implementing Blockchain Technology to Transform Telemedicine

Medical Innovation Holdings (OTC: MIHI) aims to further transform telemedicine by implementing blockchain technology into its disruptive business model. An article highlighting the innovative company reads: “With a keen eye for opportunities within niche markets of health care, MIHI’s management team recognizes that traditional means of protecting patient medical and financial data is failing, as “digital assassins” grow increasingly brazen, determined and skilled at taking sensitive data. This increasing trend is catastrophic for patients and care providers, though it provides a doorway of innovation for companies like MIHI, which sees blockchain as part of the answer to solve these critical…

Continue Reading

FridayFeb 16, 2018 12:17 pm

QualityStocksNewsBreaks – IEG Holdings Corp. (IEGH) Aims to Create Exclusive Gold Metal-backed Cryptocurrency

Consumer loan provider IEG Holdings (OTCQB: IEGH) intends to create its own gold metal-backed cryptocurrency for consumer loans and consumer loan repayments. A recent article discussing the company’s anticipated endeavor reads: “On January 10, 2018, consumer loan provider IEG Holdings Corp. (OTCQB: IEGH) announced that its wholly owned subsidiary, Investment Evolution Crypto, LLC, is negotiating to purchase a gold project with prospecting licenses and known gold resources. The corporation plans to use a gold resource for the creation of its own gold metal-backed cryptocurrency, with a view to offering loans and accepting loan repayments through blockchain technology. Investment Evolution Crypto…

Continue Reading

FridayFeb 16, 2018 12:11 pm

QualityStocksNewsBreaks – Teewinot Life Sciences Lowers Production Cost of Clinical-Grade Cannabinoids with Proprietary Synthetic Biology Technology

Teewinot Life Sciences is on a mission to cut costs of cannabinoid production while approaching the process like a pharmaceutical company, not as a cannabis firm. An article discussing the company reads: “Teewinot Life Sciences is a Tampa, Florida-based global biopharmaceutical company focused on cannabinoid clinical development utilizing patented and proprietary synthetic biology and biocatalysis technology. Its strategy involves the production and use of cannabinoid molecules. The goal of the company is to produce, at lower cost, consistent and pure cannabinoids that it believes can be used to develop superior human therapies.” To view the full article, visit http://ibn.fm/8EvOn Let…

Continue Reading

FridayFeb 16, 2018 10:42 am

QualityStocksNewsBreaks – AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Offers In-depth Analysis, Predictive Analytics with CapitalCube Online Portal

Artificial intelligence (“AI”) company AnalytixInsight (TSX.V: ALY) (OTCQB: ATIXF) has developed a financial portal that reports on over 50,000 global equities and North American ETFs. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. An article discussing the company’s innovative portal reads: “The company’s flagship product – CapitalCube.com – is a financial portal that provides comprehensive analysis that includes on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube’s online portal is meant to generate investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported…

Continue Reading

FridayFeb 16, 2018 10:31 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Strives to Educate, Bring Awareness to the Chinese-speaking Community on Cryptocurrency

Market analysis company ChineseInvestors.com (OTCQB: CIIX) has remained committed to the education and growth of cryptocurrency and is delivering innovative ways of making bitcoin more accessible to the Chinese-speaking community. An article discussing the company reads: “ChineseInvestors.com, Inc. (OTCQB: CIIX) is continuing its commitment to cryptocurrency education and awareness for the Chinese-speaking community. Its educational services seek to answer the average person’s curiosity while simultaneously providing skilled investors with up-to-date news on digital currency. Using the Chinese language character sets, CIIX provides analysis and education that is accessible to the Chinese-speaking community worldwide. CIIX provides information on how to purchase…

Continue Reading

FridayFeb 16, 2018 10:25 am

QualityStocksNewsBreaks – Why Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is “One to Watch”

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is engaged in acquiring and developing a strategic portfolio of companies that also believe in the substantial potential of the industrial hemp plant. An article discussing the company reads: “The company’s mission is to build a strategic portfolio of hemp-based companies that operate synergistically to consistently deliver a solid ROI to its shareholders. Global Hemp Group has established the concept of Hemp Agro-Industrial Zone (HAIZ) (https://globalhempgroup.com/hempagro/) in order to build cooperative mechanisms across industrial sectors with a focus on different parts of the hemp plant. Under the HAIZ strategy, Global…

Continue Reading

ThursdayFeb 15, 2018 5:11 pm

Global Hemp Group Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Aims to be a Leader in the Multi-Faceted Industrial Hemp Market

Industrial hemp is the only commodity that has the potential to generate revenue from multiple finished goods in the global food, construction materials, nutraceutical, textile and bio-energy industries Global Hemp Group completed hemp trials last year which set the stage for a full-fledged commercial hemp operation in New Brunswick, Canada, in 2018 Under Canadian law, CBD will become legal to extract from Industrial Hemp in July 2018 Hemp Business Journal estimates that the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products Official data demonstrates that the hemp industry…

Continue Reading

ThursdayFeb 15, 2018 4:21 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP): IP Portfolio, Licensing and R&D are Keys to Growth in 2018

LXRP has global patents or patents-pending in more than 40 countries, including the U.S., Australia, China, the European Union and Canada Company is working through a C$250,000 budget for an 18-month collaborative research agreement with the National Research Council Licensing is a revenue generator, with LXRP offering to license its disruptive DehydraTECH™ technology in countries where it is patented or patent-pending Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is generating revenue and knowledge through both licensing of its IP portfolio and advancement of R&D projects. It already has patents and multiple patents-pending in more than 40 countries. It has received…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered